Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,300 shares, a decline of 35.0% from the February 13th total of 2,000 shares. Based on an average daily volume of 13,600 shares, the short-interest ratio is presently 0.1 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group upgraded Carl Zeiss Meditec from a “sell” rating to a “buy” rating in a report on Tuesday.
Get Our Latest Report on CZMWY
Carl Zeiss Meditec Trading Up 7.4 %
Carl Zeiss Meditec Announces Dividend
The business also recently announced an annual dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.6246 per share. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Friday, March 28th. Carl Zeiss Meditec’s dividend payout ratio is currently 32.64%.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The 3 Best Retail Stocks to Shop for in August
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are Dividend Challengers?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.